Skip to main content

Research Repository

Advanced Search

The cannabinoid Δ9-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells

Williams, Ann C.; Patsos, Helena A.; Paraskeva, Christos; Greenhough, Alexander

Authors

Ann C. Williams

Helena A. Patsos

Christos Paraskeva



Abstract

Deregulation of cell survival pathways and resistance to apoptosis are widely accepted to be fundamental aspects of tumorigenesis. As in many tumours, the aberrant growth and survival of colorectal tumour cells is dependent upon a small number of highly activated signalling pathways, the inhibition of which elicits potent growth inhibitory or apoptotic responses in tumour cells. Accordingly, there is considerable interest in therapeutics that can modulate survival signalling pathways and target cancer cells for death. There is emerging evidence that cannabinoids, especially Δ9-tetra- hydrocannabinol (THC), may represent novel anticancer agents, due to their ability to regulate signalling pathways critical for cell growth and survival. Here, we report that CB1 and CB2 cannabinoid receptors are expressed in human colorectal adenoma and carcinoma cells, and show for the first time that THC induces apoptosis in colorectal cancer cells. THC-induced apoptosis was rescued by pharmacological blockade of the CB1, but not CB2, cannabinoid receptor. Importantly, THC treatment resulted in CB1-mediated inhibition of both RAS-MAPK/ERK and PI3K-AKT survival signalling cascades; two key cell survival pathways frequently deregulated in colorectal tumours. The inhibition of ERK and AKT activity by THC was accompanied by activation of the proapoptotic BCL-2 family member BAD. Reduction of BAD protein expression by RNA interference rescued colorectal cancer cells from THC-induced apoptosis. These data suggest an important role for CB1 receptors and BAD in the regulation of apoptosis in colorectal cancer cells. The use of THC, or selective targeting of the CBl receptor, may represent a novel strategy for colorectal cancer therapy. © 2007 Wiley-Liss, Inc.

Citation

Paraskeva, C., Patsos, H. A., Williams, A. C., & Greenhough, A. (2007). The cannabinoid Δ9-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. International Journal of Cancer, 121(10), 2172-2180. https://doi.org/10.1002/ijc.22917

Journal Article Type Article
Acceptance Date May 15, 2007
Online Publication Date Sep 25, 2007
Publication Date Nov 15, 2007
Journal International Journal of Cancer
Print ISSN 0020-7136
Electronic ISSN 1097-0215
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 121
Issue 10
Pages 2172-2180
DOI https://doi.org/10.1002/ijc.22917
Public URL https://uwe-repository.worktribe.com/output/1023643
Publisher URL https://doi.org/10.1002/ijc.22917